National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

INTRODUCTION: More than 90% of patients diagnosed with childhood acute lymphoblastic leukaemia (ALL) today will survive. However, half of the survivors are expected to experience therapy-related chronic or late occurring adverse effects, reducing quality of life. Insight into underlying risk traject...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Andrés-Jensen, Liv, Skipper, Mette Tiedemann, Mielke Christensen, Kristian, Hedegaard Johnsen, Pia, Aagaard Myhr, Katrine, Kaj Fridh, Martin, Grell, Kathrine, Pedersen, A. M. L., Leisgaard Mørck Rubak, Sune, Ballegaard, Martin, Hørlyck, Arne, Beck Jensen, Rikke, Lambine, Trine-Lise, Gjerum Nielsen, Kim, Tuckuviene, Ruta, Skov Wehner, Peder, Klug Albertsen, Birgitte, Schmiegelow, Kjeld, Frandsen, Thomas Leth
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Haematology (Incl Blood Transfusion)
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7875271/
https://ncbi.nlm.nih.gov/pubmed/33563628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-045543
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados